Your browser doesn't support javascript.
Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.
Takashita, Emi; Yamayoshi, Seiya; Fukushi, Shuetsu; Suzuki, Tadaki; Maeda, Ken; Sakai-Tagawa, Yuko; Ito, Mutsumi; Uraki, Ryuta; Halfmann, Peter; Watanabe, Shinji; Takeda, Makoto; Hasegawa, Hideki; Imai, Masaki; Kawaoka, Yoshihiro.
  • Takashita E; National Institute of Infectious Diseases, Tokyo, Japan.
  • Yamayoshi S; University of Tokyo, Tokyo, Japan.
  • Fukushi S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Suzuki T; National Institute of Infectious Diseases, Tokyo, Japan.
  • Maeda K; National Institute of Infectious Diseases, Tokyo, Japan.
  • Sakai-Tagawa Y; University of Tokyo, Tokyo, Japan.
  • Ito M; University of Tokyo, Tokyo, Japan.
  • Uraki R; University of Tokyo, Tokyo, Japan.
  • Halfmann P; University of Wisconsin-Madison, Madison, WI.
  • Watanabe S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Takeda M; National Institute of Infectious Diseases, Tokyo, Japan.
  • Hasegawa H; National Institute of Infectious Diseases, Tokyo, Japan.
  • Imai M; University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.
  • Kawaoka Y; University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.
N Engl J Med ; 387(13): 1236-1238, 2022 09 29.
Article in English | MEDLINE | ID: covidwho-2034592

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Topics: Variants Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2209952

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Topics: Variants Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2209952